Format

Send to

Choose Destination
Cancer Radiother. 2016 Feb;20(1):66-72. doi: 10.1016/j.canrad.2016.01.001. Epub 2016 Jan 22.

High dose rate brachytherapy for prostate cancer: Standard of care and future direction.

Author information

1
Cancer Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, HA6 2RN, United Kingdom.
2
Cancer Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, HA6 2RN, United Kingdom. Electronic address: peterhoskin@nhs.net.

Abstract

High dose rate brachytherapy is a highly conformal method of radiation dose escalation for prostate cancer and one of several treatment options for men with localised disease. The large doses per fraction exploit the low alpha/beta ratio of prostate cancer cells so that biological radiation dose delivered is substantially greater than that achieved with conventional external beam delivery. This review article presents contemporary data on the rationale for high dose rate brachytherapy including treatment technique and future directions.

KEYWORDS:

Adénocarcinome prostatique; Antigène spécifique de la prostate; Carcinoma; PSA; Prostatic; TRUS; Traitement; Treatment; Échographie

PMID:
26811209
DOI:
10.1016/j.canrad.2016.01.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center